These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 33393153)

  • 1. Effects of tadalafil versus silodosin on voiding function in male patients with non-neurogenic detrusor underactivity: A comparative study using propensity score matching.
    Matsukawa Y; Majima T; Funahashi Y; Fujita T; Ishida S; Kato M; Gotoh M
    Int J Urol; 2021 Apr; 28(4):411-416. PubMed ID: 33393153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and useful signs to differentiate detrusor underactivity from bladder outlet obstruction in men with non-neurogenic lower urinary tract symptoms.
    Matsukawa Y; Yoshida M; Yamaguchi O; Takai S; Majima T; Funahashi Y; Yono M; Sekido N; Gotoh M
    Int J Urol; 2020 Jan; 27(1):47-52. PubMed ID: 31542892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tadalafil on storage and voiding function in patients with male lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A urodynamic-based study.
    Matsukawa Y; Majima T; Matsuo K; Funahashi Y; Kato M; Yamamoto T; Gotoh M
    Int J Urol; 2018 Mar; 25(3):246-250. PubMed ID: 29164680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two types of detrusor underactivity in men with nonneurogenic lower urinary tract symptoms.
    Matsukawa Y; Naito Y; Ishida S; Matsuo K; Majima T; Gotoh M
    Neurourol Urodyn; 2023 Jan; 42(1):73-79. PubMed ID: 36125443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Functional changes during the voiding phase in males with non-neurogenic detrusor underactivity undergoing bladder catheterization.].
    Vírseda-Chamorro M; Salinas-Casado J; Méndez-Rubio S; Barroso Manso Á; Esteban-Fuertes M
    Arch Esp Urol; 2019 Jul; 72(6):564-569. PubMed ID: 31274121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Objective impacts of tadalafil on storage and voiding function in male patients with benign prostatic hyperplasia: 1-year outcomes from a prospective urodynamic study.
    Matsukawa Y; Takai S; Majima T; Funahashi Y; Sassa N; Kato M; Yamamoto T; Gotoh M
    World J Urol; 2019 May; 37(5):867-872. PubMed ID: 30121825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urodynamics of men with urinary retention.
    Guo DP; Comiter CV; Elliott CS
    Int J Urol; 2017 Sep; 24(9):703-707. PubMed ID: 28687026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an artificial intelligence diagnostic system for lower urinary tract dysfunction in men.
    Matsukawa Y; Kameya Y; Takahashi T; Shimazu A; Ishida S; Yamada M; Sassa N; Yamamoto T
    Int J Urol; 2021 Nov; 28(11):1143-1148. PubMed ID: 34342055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unravelling detrusor underactivity: Development of a bladder outlet resistance-Bladder contractility nomogram for adult male patients with lower urinary tract symptoms.
    Oelke M; Rademakers KL; van Koeveringe GA;
    Neurourol Urodyn; 2016 Nov; 35(8):980-986. PubMed ID: 26235823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin can be a good predictor of urodynamic detrusor underactivity: a prospective study in men with lower urinary tract symptoms.
    Ishikawa T; Matsukawa Y; Naito Y; Ishida S; Majima T; Gotoh M
    World J Urol; 2023 Apr; 41(4):1117-1124. PubMed ID: 36823359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Video-urodynamic characteristics of non-neurogenic, idiopathic underactive bladder in men - A comparison of men with normal tracing and bladder outlet obstruction.
    Jiang YH; Kuo HC
    PLoS One; 2017; 12(4):e0174593. PubMed ID: 28376105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous voiding is surprisingly recoverable via outlet procedure in men with underactive bladder and documented detrusor underactivity on urodynamics.
    Dobberfuhl AD; Chen A; Alkaram AF; De EJB
    Neurourol Urodyn; 2019 Nov; 38(8):2224-2232. PubMed ID: 31432550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis.
    Osman NI; Chapple CR; Abrams P; Dmochowski R; Haab F; Nitti V; Koelbl H; van Kerrebroeck P; Wein AJ
    Eur Urol; 2014 Feb; 65(2):389-98. PubMed ID: 24184024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detrusor contraction power parameters (BCI and W max) rise with increasing bladder outlet obstruction grade in men with lower urinary tract symptoms: results from a urodynamic database analysis.
    Oelke M; Rademakers KL; van Koeveringe GA
    World J Urol; 2014 Oct; 32(5):1177-83. PubMed ID: 25007993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of flow rate curve shape and video-urodynamic findings in women with lower urinary tract symptoms: can flow rate curve shape predict female bladder outflow obstruction or detrusor underactivity?
    Kocadag H; Toia B; Axell R; Yasmin H; Pakzad MH; Hamid R; Greenwell TJ; Ockrim JL
    World J Urol; 2021 May; 39(5):1591-1595. PubMed ID: 32653952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-specific prevalence, clinical and urodynamic findings of detrusor underactivity and bladder outlet obstruction in female voiding dysfunction.
    Wu PC; Hsiao SM; Lin HH
    Int J Gynaecol Obstet; 2024 Nov; 167(2):797-803. PubMed ID: 38800864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urodynamic characteristics of detrusor underactivity in women with voiding dysfunction.
    Yang TH; Chuang FC; Kuo HC
    PLoS One; 2018; 13(6):e0198764. PubMed ID: 29924821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous adipose-derived mesenchymal stem cell therapy reverses detrusor underactivity: open clinical trial.
    Coelho HRS; Neves SCD; da Silva Menezes JN; Antoniolli-Silva ACMB; Oliveira RJ
    Stem Cell Res Ther; 2023 Apr; 14(1):64. PubMed ID: 37016455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
    Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S
    J Urol; 2013 Jan; 189(1 Suppl):S135-40. PubMed ID: 23234619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detrusor underactivity versus bladder outlet obstruction clinical and urodynamic factors.
    Kalil J; D Ancona CAL
    Int Braz J Urol; 2020; 46(3):419-424. PubMed ID: 32167707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.